RALA and cancer: As an additional method of confirming if RALA phosphorylation does not affect RALA activation in these cancers, we asked if VMLN-mediated inhibition of AURKA (that was seen to differentially affect RALA phosphorylation in MCF7 versus MiaPaCa2 cells) (Fig. 2C) affects RALA activation differently (Fig. S3D).